Mark Costar holds AstraZeneca in his portfolio and is quizzed about Nvidia. He also holds HSBC. AstraZeneca is listed on the London Stock Exchange.

The entities involved

• Mark →

  researcher ORCID ID = 0000-0002-4304-1174

  • Mark joined the capital markets team at Opus, a national leader, in Minneapolis.Thu 16:50
• AstraZeneca →

  British-Swedish pharmaceutical company

  • AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
  • Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
• Nvidia →

  American multinational technology company

  • Apple is utilizing TSMC for advanced chip manufacturing, a trend observed alongside market pricing pressures affecting sales volume.Mon 17:45
  • A market sell-off hit major chip companies (AMD, Intel, Micron, Samsung, Nvidia) as the AI trade cooled and investors entered risk-off mode.Mon 17:34
• HSBC →

  British multinational bank

  • HSBC utilized its Orion platform for a bond issuance, which was reported by Reuters and involves S&P sovereign ratings for Hong Kong.Mon 06:51
  • Alphabet filed a disclosure with the SEC and HSBC partnered with Google Cloud for AI.Mon 05:51

Related events

• Rothschild & Co Asset Management added Amphenol as a new holding in its fund portfolio on August 28, 2026.Aug 28
• Nvidia board member Mark Stevens filed required regulatory documents with the SEC.Sep 7
• Nvidia CEO Jensen Huang spoke at a conference in Seoul. Meanwhile, Anthony Noto bought SoFi stock, Elon Musk purchased Tesla stock, and Jamie Dimon bought shares of JPMorgan Chase.Aug 25
• HSBC and Nu Holdings are both identified as large-cap finance companies.Sep 10
• HSBC has issued a rating regarding the stock of Hexaware Technologies.Sep 3